Skip to main content

Hong Kong

  • NMPA GLP-certified facility

  • 30% reduction in timelines with integrated program management

  • Optimize clinical trial enrollment with Xcellerate®, our data-driven drug development approach

At the Hong Kong office, we can handle all your drug development services with our local knowledge and regional facilities. Trust in our high-quality, on time delivery to help your product reach the market earlier. 

Solutions in Hong Kong

We leverage our experience to share unique perspectives and ultimately deliver your results. Partner with our Hong Kong team to access solutions from our neighboring operational units and global resources.

Central Laboratory Services: Trust in the experience of the Singapore central lab to deliver consistent, quality data and on-time data transfers for faster submissions. Operating since 2000, we offer one of the biggest central laboratories in the world, serving 16 countries in the Asia Pacific region. Central laboratory facilities and services are also available in Shanghai, China.

Nonclinical Development Services: Leverage our dedicated expertise and operations across the region to deliver unique perspectives on your development program. Our NMPA GLP certified facility in Shanghai, China features a number of accreditations to fulfill global quality standards (FDA, OECD, etc.). Specific solutions for small molecules and biologics are available to reduce costs and gain efficiencies for your project. 

As your partner, our diverse network of local scientific experts can meet your global requirements in any phase of drug development and help you reach decision points.

  • Regulatory expertise: Get experienced consulting with your regulatory submissions from our local personnel.
  • Site monitoring: Ensure patient safety, data quality and your study’s integrity with our holistic site monitoring solutions.
  • Project management: Receive expert guidance through any phase of your clinical trial by working alongside our dedicated project managers.

Local Expertise

With a high density of international companies and Cantonese and English as the official languages, Hong Kong is considered a strategic location for business in the Asia Pacific region. Hong Kong has other attractive factors in the drug development landscape:

  • Centralized infrastructure: Hong Kong’s concentrated patient population and centralized healthcare system make it natural choice for conducting clinical trials.
  • Favorable regulatory environment: Typical approval timelines are three months and some accredited Hong Kong sites may also be used to support drug registration in China.
  • Gateway to China: Based on location, language, and cultural similarities, Hong Kong is a natural base for connecting with Chinese collaborators.
     

Locations

Whether supporting a global trial in Hong Kong or including it as part of a regional Chinese-focused trial, we are ready to help you deliver results.  

Sales Enquiries:
+86 21 6171 1245

General Enquiries:
+852 2588 6816

Office Address:
Covance Hong Kong Services Limited
Rm4703a, 47/F
Central Plaza
18 Harbour Road,
Wanchai, Hong Kong

Let's start a conversation